Cannabis Investors: Canopy Growth (TSX:WEED) Just Became a Strong Buy!

Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) just became a timely buy for growth investors looking for long-term outperformance.

| More on:
edit Cannabis leaves of a plant on a dark background

Image source: Getty Images

The cannabis trade is dead, at least according to most traders looking to make a quick buck off pot stocks like Canopy Growth (TSX:WEED)(NYSE:CGC). For long-term cannabis investors seeking to hold for the next 10, 20, or 30 years, though, now is as good a time as any to initiate a position given that the cannabis bubble has finally had a chance to burst.

Now that there’s less hype surrounding the cannabis space, alcohol kingpin Constellation Brands decided to increase its stake in cannabis kingpin Canopy Growth through the exercise of warrants.

Constellation Brands’ increased involvement in Canopy Growth makes WEED stock a must-buy

The cannabis trade may indeed be dead, with Canopy Growth now down around 70% from its all-time highs. However, the long-term opportunity still exists with Constellation’s deep pockets and expertise readily at the disposal of Canopy.

The company now has what it takes to become a dominant leader in the budding industry still in the early innings of its growth story.

I’m a massive fan of Constellation’s decision to scale into a larger position gradually over time and think hungry investors should seek to follow the alcohol behemoth by averaging into a position as well.

The cannabis industry suffered a dot-com-like bubble burst, and now that most pot stocks out there have lost a majority of their value, a few well-equipped firms, such as Canopy Growth, are well positioned to rise out from the rubble and provide meaningful growth to investors with the patience to hold for the long haul.

Canopy Growth: A new man at the helm

Canopy has continued to burn through cash at an unprecedented rate. Still, with Constellation standing in its corner with a now hefty investment and new CEO David Klein (Constellation’s previous CFO), Canopy is one of the few licensed cannabis producers that have evolved to become more of an investment and less of a speculative gamble over the past year.

Klein provides the expertise that Canopy needs to take its business to the next level. With the now modest valuation, the Canopy Growth stock actually looks to have a pretty decent risk/reward trade-off.

At the time of writing, Canopy Growth stock trades at 1.6 times book and just shy of 20 times sales. On a price-to-sales basis, Canopy isn’t exactly a cheap stock.

Still, younger Canadian investors should consider getting a bit of skin in the game with their Tax-Free Savings Accounts (TFSAs), as I have a feeling that Constellation has created a relative support level for what looked to be a free-falling knife of a stock.

Foolish takeaway

A majority of speculators have moved on from the cannabis trade, which is precisely why investors should consider getting in now alongside Constellation Brands. Canopy Growth has both the expertise and pockets to emerge as a leader in the space.

With a potential U.S. legalization in the cards over the next decade and beyond, investors would be wise to stash the stock in their TFSA and just let it sit for decades at a time.

Stay hungry. Stay Foolish.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Joey Frenette has no position in any of the stocks mentioned.

More on Cannabis Stocks

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Canopy Growth (TSX:WEED) Tanks Again: How Low Could the Stock Go?

Canopy Growth just reported weak quarterly results. What's next for this cannabis stock?

Read more »

Pot stocks
Cannabis Stocks

Canopy Growth Stock Falls 13% as Revenue Falls 25% on Lower Sales

Canopy Growth (TSX:WEED)(NASDAQ:CGC) stock beat earnings estimates in Q4 but saw net revenue drop year over year by 25%.

Read more »

Cannabis stocks have fallen.
Cannabis Stocks

Why Tilray Will Be the First Cannabis Stock to Bounce Back

Tilray is down 38% year to date, but it's one of the only profitable cannabis companies out there.

Read more »

Pot stocks
Cannabis Stocks

Canopy Growth: What Went Wrong?

Before cannabis was legalized in Canada, this stock was soaring, as was its public profile.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Is Cronos Group (TSX:CRON) a Buy After its 1st-Quarter Performance?

Cronos Group remains a high-risk, high-reward stock, despite its solid first-quarter performance.

Read more »

Cannabis smoke
Cannabis Stocks

Aurora Cannabis Stock Hits 52-Week Low: What Investors Should Know

Aurora Cannabis stock continues to fall, hitting a yearly bottom last week. So what should investors do now?

Read more »

edit Jars of marijuana
Cannabis Stocks

Here’s Why Curaleaf Is a Better Cannabis Stock Compared to Sundial!

Cannabis giant Curaleaf ended 2021 with $1.2 billion in sales, making it one of the largest marijuana companies in the…

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

2 Cannabis Stocks Better Than Sundial Growers

Here's why Green Thumb Industries and Cresco Labs are much better long-term bets compared to Sundial Growers.

Read more »